Free Trial

Alphatec (ATEC) Competitors

Alphatec logo
$8.40 +0.12 (+1.43%)
As of 10:02 AM Eastern
This is a fair market value price provided by Massive. Learn more.

ATEC vs. ITGR, SMA, ATRC, IART, and ANGO

Should you buy Alphatec stock or one of its competitors? MarketBeat compares Alphatec with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Alphatec include Integer (ITGR), Smartstop Self Storage REIT (SMA), AtriCure (ATRC), Integra LifeSciences (IART), and AngioDynamics (ANGO). These companies are all part of the "health care equipment" industry.

How does Alphatec compare to Integer?

Integer (NYSE:ITGR) and Alphatec (NASDAQ:ATEC) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

99.3% of Integer shares are owned by institutional investors. Comparatively, 66.3% of Alphatec shares are owned by institutional investors. 1.1% of Integer shares are owned by company insiders. Comparatively, 13.5% of Alphatec shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Integer has a net margin of 7.64% compared to Alphatec's net margin of -15.93%. Integer's return on equity of 12.83% beat Alphatec's return on equity.

Company Net Margins Return on Equity Return on Assets
Integer7.64% 12.83% 6.51%
Alphatec -15.93%-1,183.84%-15.83%

Integer has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integer$1.85B1.67$102.81M$4.0122.75
Alphatec$787.08M1.64-$143.36M-$0.82N/A

In the previous week, Alphatec had 8 more articles in the media than Integer. MarketBeat recorded 9 mentions for Alphatec and 1 mentions for Integer. Integer's average media sentiment score of 1.35 beat Alphatec's score of 0.66 indicating that Integer is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integer
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alphatec
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Integer currently has a consensus price target of $98.71, indicating a potential upside of 8.23%. Alphatec has a consensus price target of $18.58, indicating a potential upside of 121.28%. Given Alphatec's stronger consensus rating and higher probable upside, analysts clearly believe Alphatec is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer
1 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.27
Alphatec
1 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.75

Integer has a beta of 0.66, meaning that its share price is 34% less volatile than the broader market. Comparatively, Alphatec has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market.

Summary

Integer beats Alphatec on 10 of the 16 factors compared between the two stocks.

How does Alphatec compare to Smartstop Self Storage REIT?

Smartstop Self Storage REIT (NYSE:SMA) and Alphatec (NASDAQ:ATEC) are both small-cap health care equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations, media sentiment and institutional ownership.

Smartstop Self Storage REIT has a net margin of 4.38% compared to Alphatec's net margin of -15.93%. Smartstop Self Storage REIT's return on equity of 1.00% beat Alphatec's return on equity.

Company Net Margins Return on Equity Return on Assets
Smartstop Self Storage REIT4.38% 1.00% 0.54%
Alphatec -15.93%-1,183.84%-15.83%

Smartstop Self Storage REIT has higher earnings, but lower revenue than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Smartstop Self Storage REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Smartstop Self Storage REIT$294.00M6.13-$1.55M$0.15217.04
Alphatec$787.08M1.64-$143.36M-$0.82N/A

66.3% of Alphatec shares are held by institutional investors. 5.5% of Smartstop Self Storage REIT shares are held by insiders. Comparatively, 13.5% of Alphatec shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Alphatec had 8 more articles in the media than Smartstop Self Storage REIT. MarketBeat recorded 9 mentions for Alphatec and 1 mentions for Smartstop Self Storage REIT. Smartstop Self Storage REIT's average media sentiment score of 1.21 beat Alphatec's score of 0.66 indicating that Smartstop Self Storage REIT is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Smartstop Self Storage REIT
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alphatec
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Smartstop Self Storage REIT presently has a consensus target price of $37.17, indicating a potential upside of 14.16%. Alphatec has a consensus target price of $18.58, indicating a potential upside of 121.28%. Given Alphatec's stronger consensus rating and higher possible upside, analysts clearly believe Alphatec is more favorable than Smartstop Self Storage REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Smartstop Self Storage REIT
1 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
2 Strong Buy rating(s)
2.73
Alphatec
1 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.75

Smartstop Self Storage REIT has a beta of 0.68, indicating that its stock price is 32% less volatile than the broader market. Comparatively, Alphatec has a beta of 0.88, indicating that its stock price is 12% less volatile than the broader market.

Summary

Smartstop Self Storage REIT beats Alphatec on 9 of the 17 factors compared between the two stocks.

How does Alphatec compare to AtriCure?

AtriCure (NASDAQ:ATRC) and Alphatec (NASDAQ:ATEC) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, media sentiment, institutional ownership and valuation.

AtriCure has a net margin of -0.83% compared to Alphatec's net margin of -15.93%. AtriCure's return on equity of 0.29% beat Alphatec's return on equity.

Company Net Margins Return on Equity Return on Assets
AtriCure-0.83% 0.29% 0.22%
Alphatec -15.93%-1,183.84%-15.83%

99.1% of AtriCure shares are held by institutional investors. Comparatively, 66.3% of Alphatec shares are held by institutional investors. 4.0% of AtriCure shares are held by insiders. Comparatively, 13.5% of Alphatec shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

AtriCure presently has a consensus target price of $48.71, indicating a potential upside of 67.81%. Alphatec has a consensus target price of $18.58, indicating a potential upside of 121.28%. Given Alphatec's stronger consensus rating and higher probable upside, analysts clearly believe Alphatec is more favorable than AtriCure.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AtriCure
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.64
Alphatec
1 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.75

In the previous week, Alphatec had 5 more articles in the media than AtriCure. MarketBeat recorded 9 mentions for Alphatec and 4 mentions for AtriCure. Alphatec's average media sentiment score of 0.66 beat AtriCure's score of 0.16 indicating that Alphatec is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AtriCure
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Alphatec
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

AtriCure has higher earnings, but lower revenue than Alphatec. AtriCure is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AtriCure$534.53M2.75-$11.45M-$0.10N/A
Alphatec$787.08M1.64-$143.36M-$0.82N/A

AtriCure has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market. Comparatively, Alphatec has a beta of 0.88, suggesting that its share price is 12% less volatile than the broader market.

Summary

AtriCure beats Alphatec on 9 of the 17 factors compared between the two stocks.

How does Alphatec compare to Integra LifeSciences?

Alphatec (NASDAQ:ATEC) and Integra LifeSciences (NASDAQ:IART) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

Alphatec has a net margin of -15.93% compared to Integra LifeSciences' net margin of -30.15%. Integra LifeSciences' return on equity of 17.42% beat Alphatec's return on equity.

Company Net Margins Return on Equity Return on Assets
Alphatec-15.93% -1,183.84% -15.83%
Integra LifeSciences -30.15%17.42%5.00%

Alphatec has a beta of 0.88, indicating that its share price is 12% less volatile than the broader market. Comparatively, Integra LifeSciences has a beta of 1.24, indicating that its share price is 24% more volatile than the broader market.

66.3% of Alphatec shares are owned by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are owned by institutional investors. 13.5% of Alphatec shares are owned by insiders. Comparatively, 3.8% of Integra LifeSciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Alphatec has higher earnings, but lower revenue than Integra LifeSciences. Alphatec is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alphatec$787.08M1.64-$143.36M-$0.82N/A
Integra LifeSciences$1.64B0.85-$516.47M-$6.46N/A

In the previous week, Alphatec had 4 more articles in the media than Integra LifeSciences. MarketBeat recorded 9 mentions for Alphatec and 5 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 0.77 beat Alphatec's score of 0.66 indicating that Integra LifeSciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alphatec
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Integra LifeSciences
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Alphatec presently has a consensus price target of $18.58, suggesting a potential upside of 121.28%. Integra LifeSciences has a consensus price target of $14.00, suggesting a potential downside of 21.98%. Given Alphatec's stronger consensus rating and higher possible upside, analysts clearly believe Alphatec is more favorable than Integra LifeSciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alphatec
1 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.75
Integra LifeSciences
2 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

Summary

Alphatec beats Integra LifeSciences on 9 of the 16 factors compared between the two stocks.

How does Alphatec compare to AngioDynamics?

Alphatec (NASDAQ:ATEC) and AngioDynamics (NASDAQ:ANGO) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

Alphatec has a beta of 0.88, indicating that its share price is 12% less volatile than the broader market. Comparatively, AngioDynamics has a beta of 0.38, indicating that its share price is 62% less volatile than the broader market.

AngioDynamics has a net margin of -10.01% compared to Alphatec's net margin of -15.93%. AngioDynamics' return on equity of -4.66% beat Alphatec's return on equity.

Company Net Margins Return on Equity Return on Assets
Alphatec-15.93% -1,183.84% -15.83%
AngioDynamics -10.01%-4.66%-3.08%

AngioDynamics has lower revenue, but higher earnings than Alphatec. AngioDynamics is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alphatec$787.08M1.64-$143.36M-$0.82N/A
AngioDynamics$313.73M1.61-$33.99M-$0.75N/A

Alphatec presently has a consensus price target of $18.58, indicating a potential upside of 121.28%. AngioDynamics has a consensus price target of $18.67, indicating a potential upside of 53.07%. Given Alphatec's stronger consensus rating and higher probable upside, research analysts plainly believe Alphatec is more favorable than AngioDynamics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alphatec
1 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.75
AngioDynamics
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.67

In the previous week, Alphatec had 4 more articles in the media than AngioDynamics. MarketBeat recorded 9 mentions for Alphatec and 5 mentions for AngioDynamics. Alphatec's average media sentiment score of 0.66 beat AngioDynamics' score of 0.46 indicating that Alphatec is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alphatec
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AngioDynamics
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

66.3% of Alphatec shares are held by institutional investors. Comparatively, 89.4% of AngioDynamics shares are held by institutional investors. 13.5% of Alphatec shares are held by insiders. Comparatively, 6.0% of AngioDynamics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Alphatec beats AngioDynamics on 10 of the 17 factors compared between the two stocks.

Get Alphatec News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATEC vs. The Competition

MetricAlphatecMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.29B$7.10B$6.49B$12.31B
Dividend YieldN/A1.21%2.67%5.66%
P/E Ratio-10.2448.6624.0524.76
Price / Sales1.6483.85542.61168.32
Price / CashN/A25.5927.4837.92
Price / Book104.986.9510.696.90
Net Income-$143.36M$159.20M$3.57B$337.45M
7 Day Performance6.17%0.12%1.56%2.84%
1 Month Performance9.63%6.17%2.49%4.78%
1 Year Performance-24.07%3.22%26.51%33.08%

Alphatec Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATEC
Alphatec
3.7624 of 5 stars
$8.40
+1.4%
$18.58
+121.3%
-25.1%$1.29B$787.08MN/A700
ITGR
Integer
2.273 of 5 stars
$91.79
-0.2%
$98.71
+7.5%
-23.0%$3.12B$1.85B22.8911,000
SMA
Smartstop Self Storage REIT
3.7699 of 5 stars
$31.66
+2.4%
$37.17
+17.4%
-9.8%$1.71B$294.00M211.05N/A
ATRC
AtriCure
4.0394 of 5 stars
$26.92
-0.7%
$48.71
+81.0%
-9.0%$1.37B$534.53MN/A1,300
IART
Integra LifeSciences
1.3954 of 5 stars
$16.94
-0.3%
$14.00
-17.4%
+46.1%$1.32B$1.64BN/A4,427

Related Companies and Tools


This page (NASDAQ:ATEC) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners